🟢 NeOnc Technologies Holdings is trading 10.25% up today after Roth/MKM initiated coverage with a Buy rating

NeOnc Technologies Holdings is trading 10.25% up now at $3.55 after Roth/MKM initiated coverage on September 24, 2026, with a Buy rating and a $20 price target.

• The analyst highlighted the development outlook for NEO100 and NEO212, including potential pivotal trials before the end of 2026.
• Projected launches are in 2029 and 2030. The move is company-specific despite broader biotech weakness.